Navigation Links
EXCOR

ProductsEXCOR
Company Berlin Heart AG
Item EXCOR
Features 
  • Extremely long service life
  • Heparin coating (Carmeda)
  • Two highly-perfected independent valve systems
  • Easy air bleeding with de-airing stub and de-airing kit
  • Berlin Heart cannulas can be permanently implanted
  • Wide selection of atrial, arterial, and apex cannulas
  • Wide selection of cannulas for infants available in three sizes
  • Custom models for new surgical techniques are available on request
  • Intelligent control concept
  • Physiologically adaptive synchronous operation
  • Maximum safety through emergency valve
  • Low weight driving unit (without power packs 6.5 kg, with two power packs 8.7 kg)
Description For many patients with a diseased heart, the only therapy solution open to them is to be given a heart transplant. However, donor organs are not always readily available. For this reason, too many people die while they are on the waiting list for a donor organ.

This is where ventricular assist devices (VAD) can save the life of a patient. On the one hand, these systems can bridge the waiting period before a heart transplant is possible, on the other, they can ease a diseased heart's workload, even to the point of complete recovery.

Info Berlin Heart AG
Customer Service: +49-(0)30-8187-2600
Web site: http://www.berlinheart.com

Related medicine products :

1. Veris Standard 21"
2. Veris Compact
3. Veris Fundus
4. Veris Compact™
5. Verisyse/ ARTISAN Phakic IOL
6. Verisyse Phakic IOL
7. M.R.I. Vital Port Systems (standard size)
8. Titanium Vital Port Systems (standard size)
9. Petite Titanium Vital Port Systems
10. Petite M.R.I. Vital Port Systems
11. Mini Titanium Vital Port Systems
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
For use with catalog #0540, 0887....
Enzyme Immunoassay of D-Dimer by ELISA Method, 96 tests....
Detection of Lupus Anticoagulants. Freeze-dried hexagonal phase phos-phatidylethanolamine; normal plasmawith heparin inhibitor; PTT-LS reagent of cephalin and particulate siliceous activator;all free...
Medicine Products:
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , Belgium , June ... MKT: VNRX), today announced the appointment of Dr. ... of Directors as a Non-Executive Director, effective June ... Company,s Audit, Compensation and Nominations and Governance Committees.  ... Dr. Futcher will provide independent expertise and strategic ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
Breaking Medicine Technology: